Unknown

Dataset Information

0

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

ABSTRACT:

SUBMITTER: Chan WY 

PROVIDER: S-EPMC8652995 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Chan Wei Yee WY   Howells Lara L   Wilson William W   Sanchez Emilie E   Ainley Louise L   Chavda Selina J SJ   Dowling Emma E   Correia Nuno N   Lecat Catherine S Y CSY   McMillan Annabel A   Wisniowski Brendan B   Mahmood Shameem S   Papanikolaou Xenofon X   Lee Lydia L   Sive Jonathan J   Kyriakou Charalampia C   Wechalekar Ashutosh A   Popat Rakesh R   Rabin Neil N   Nastouli Eleni E   Yong Kwee L KL   Xu Ke K  

British journal of haematology 20211010 3

Similar Datasets

Unknown Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients.
| S-EPMC9250869 | biostudies-literature
Unknown Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination.
| S-EPMC9316698 | biostudies-literature
Unknown Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination.
| S-EPMC8733188 | biostudies-literature
Unknown Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies.
| S-EPMC8877446 | biostudies-literature
Unknown Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies.
| S-EPMC8705736 | biostudies-literature
Unknown Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19.
| S-EPMC9974059 | biostudies-literature
Unknown Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
| S-EPMC8314734 | biostudies-literature
Unknown Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
| S-EPMC8926322 | biostudies-literature
Unknown Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
| S-EPMC8275842 | biostudies-literature
Unknown Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval.
| S-EPMC9385402 | biostudies-literature